<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1237">
  <stage>Registered</stage>
  <submitdate>27/04/2006</submitdate>
  <approvaldate>27/04/2006</approvaldate>
  <actrnumber>ACTRN12606000146594</actrnumber>
  <trial_identification>
    <studytitle>A comparison of ketorolac with morphine in the treatment of acute renal colic</studytitle>
    <scientifictitle>A prospective randomised controlled trial comparing the efficacy of intravenous morphine, intravenous ketorolac and the combination of these medications in acute renal colic in the emergency department</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Renal colic</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>ketorolac tromethamine - single 30mg intravenous dose</interventions>
    <comparator>morphine sulphate - single 10mg intravenous dose</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain relief</outcome>
      <timepoint>At 10 minutes, 20 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours and 6 hours after administration of medication</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion of patients discharged from hospital.</outcome>
      <timepoint>At hourly intervals for first 6 hours after administration of medication.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Able to give informed consentsuspected diagnosis of renal colic on presentation.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnancy or breast feedinghistory of renal impairment (including renal transplant)hepatic impairmentbleeding diathesisactive peptic ulcer diseasehypersensitivity to aspirin or nonsteroidal antiinflammatory drugshypersensitivity to morphinecurrently taking lithium or methotrexatesuspected volume depletion based on clinical examinationnon-English speaking (unfortunately funding limitations make it impossible to provide consent forms and information in languages other than English).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>The person who determines if a subject is eligible for inclusion will contact an unblinded worker in the emergency department who will perform randomisation into one of three groups via an internet random number generator (https://randomiser.org/form.htm).  This worker will then prepare medications so that they appear identical for administration in a blinded fashion by researchers</concealment>
    <sequence>random number generator (http://www.randomizer.org/form.htm) will be used for randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/08/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>150</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Paul Young</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>St Vincent's Hospital Emergency Department Budget</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this project is to help determine the most effective way to treat the acute pain associated with passage of a kidney stone.  

Standard treatment for renal colic involves the use of intravenous morphine titrated to effect.  This study will involve comparison of intravenous morphine with ketorolac.  This agent is a non-steroidal anti-inflammatory drug which will be given intravenously.  In this study, patients will be given morphine, ketorolac or a combination of both of these medications.  

The hypothesis that is being tested is that ketorolac provides superior pain relief to morphine in acute renal colic.

This is a double blinded study - both the treating doctors and the patients will be blinded to the interventions administered</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St Vincent's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Paul Young</name>
      <address>c/o Emergency Department
St Vincent's Health
P O Box 2900
Fitzroy
Victoria 3065 </address>
      <phone>(03) 9288 2211</phone>
      <fax>9288 3399</fax>
      <email>pauljyoung@svhm.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Paul Young</name>
      <address>St Vincents Hospital
Fitzroy</address>
      <phone>92882211</phone>
      <fax />
      <email>pauljyoung@svhm.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>